Unidos Contra la Diabetes to Host 2025 Mini-Symposium and Annual Dia-Beat-IT Health Fair, Nov. 5th

Community partners prepare for a significant diabetes awareness and prevention event in the RGV

Translate to Spanish or other 102 languages!

Unidos Contra la Diabetes (UCD) has announced that its 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair is less than a month away. Moises Arjona Jr., MS, CHWI, Collective Impact Director for UCD, reminded community partners and stakeholders of the upcoming event, encouraging participation and support. Image for illustration purposes
Unidos Contra la Diabetes (UCD) has announced that its 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair is less than a month away. Moises Arjona Jr., MS, CHWI, Collective Impact Director for UCD, reminded community partners and stakeholders of the upcoming event, encouraging participation and support. Image for illustration purposes
- Advertisement -

By Roberto Hugo González

Mega Doctor News

Texas Border Business

- Advertisement -

Unidos Contra la Diabetes (UCD) has announced that its 2025 Mini-Symposium and Annual Dia-Beat-IT Health Fair is less than a month away. Moises Arjona Jr., MS, CHWI, Collective Impact Director for UCD, reminded community partners and stakeholders of the upcoming event, encouraging participation and support.

The Mini-Symposium is scheduled to take place on November 5, 2025, from 9:00 a.m. to 12:00 p.m. at South Texas College’s Mid-Valley Campus, located at 400 N. Border Ave. in Weslaco, Texas. Registration for the symposium is now open through the official link provided by UCD.  www.ucdrgv.org

Select the file below for more details:

In his announcement, Arjona emphasized the importance of the gathering, stating that the event “is a great opportunity to raise awareness about the growing rates of diabetes in the RGV, as well as other pressing issues such as food insecurity and access to health insurance.” He also encouraged elected officials to attend and welcome guests.

- Advertisement -

The organization has shared flyers featuring both the symposium’s speaker lineup and details of the Dia-Beat-IT Health Fair. These materials are being distributed across the Rio Grande Valley to increase outreach and community involvement.

UCD has established a reputation as a collaborative initiative dedicated to diabetes prevention in the region. According to the organization, “Unidos Contra la Diabetes is a collective impact initiative, with community partnerships dedicated to preventing diabetes in the Rio Grande Valley. We bring people together in a structured way to achieve social, behavioral, and sustainable community change.”

Founded in 2014, UCD began as a coalition of community leaders dedicated to improving health outcomes in the Rio Grande Valley by focusing on prediabetes and diabetes prevention. The group works alongside hospitals, community clinics, universities, foundations, and faith-based organizations.

“Our mission is to focus on upstream, strategic, and sustainable changes that strengthen families and communities,” the initiative stated. By uniting partners across Hidalgo, Willacy, Cameron, and Starr counties, UCD aims to enhance its impact on reducing diabetes rates while addressing related issues, including nutrition and access to healthcare.

Community members, stakeholders, and local leaders are invited to participate in the symposium and health fair, which will help continue building momentum in the fight against diabetes in the Rio Grande Valley.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.
- Advertisement -